Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03282890 · ClinicalTrials.gov registry record · NA
Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 237
- Enrollment target
NCT03282890 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 237 participants.
The verdict
NCT03282890, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and cost-effectiveness of CHRP-BB - an integrated bio-behavioral approach that incorporates the use of PrEP - with an evidence-based behavioral approach aimed at enhancing PrEP adherence and HIV risk reduction among high risk PWUD.
Interventions
- OTHER CHRP-BB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2023-10-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03282890
The ClinicalTrials.gov registry entry for NCT03282890 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CHRP-BB is the first listed.
NCT03282890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03282890 about?
NCT03282890 is a clinical study titled "Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs". This study will evaluate the efficacy and cost-effectiveness of CHRP-BB - an integrated bio-behavioral approach that incorporates the use of PrEP - with an evidence-based behavioral approach aimed at enhancing PrEP adherence and HIV risk reduction among high risk PWUD.
What is the current status of trial NCT03282890?
This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2017-11-20. Estimated completion is 2023-10-13.
What interventions are being tested in trial NCT03282890?
The interventions under investigation include: CHRP-BB (OTHER).
Who is sponsoring clinical trial NCT03282890?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.